We are excited to announce a new segment for you, How to Invest Series. Where we will be revisiting some of the smart insights, tips, and advice from our past guests on the show. To start off the series we will be touching on the Biotech and life science subject. So, let’s dive right in and hear the answers to the question I made to each of our guests back in 2021: What makes for a successful company in this segment?

Our first five guests are: Carter Williams, CEO and Managing Partner of iSelect Fund, Maximilian Bade, Founding Partner at Nucleus Capital, Orrin Ailloni-Charas, MD, who was the Managing Partner of the Global Health Impact Fund, Eyal Lifschitz, Co-Founder and Managing Partner at Peregrine Ventures, and Ron Paliwoda, President of the Paliwoda Group.

Carter Williams, a seasoned innovator and venture investor, has an extensive background in managing R&D and spearheading technological advancements. Currently, Carter leads iSelect, an early-stage venture firm based in St. Louis, which focuses on investing in companies tackling global issues with financially attractive business models. Maximilian has founded Nucleus Capital to support purpose-driven entrepreneurs addressing systemic challenges to planetary health. Nucleus Capital is a venture capital firm focused on investing in pre/seed stage companies at the intersection of synthetic biology, climate- and food technology.

Dr. Orrin Ailloni-Charas is an experienced anesthesiologist and investment leader, with a diverse background in healthcare. In 2021, he was the CEO and Managing Partner of the Global Health Impact Fund (GHIF), a physician-led venture fund. Eyal, is an experienced entrepreneur and VC partner, with over 20 years of experience managing and investing in healthcare companies. Peregrine Ventures is a leading Israeli capital fund focused on high-tech companies in the life sciences, pharma, and digital health. Ron Paliwoda is an accidental entrepreneur and seasoned investor, primarily through the Ventures arm of The Paliwoda Group.

For a full transcript, click here.

Links from today’s show:

iSelect Fund: www.iselectfund.com; Nucleus Capital: www.nucleus-capital.com; Global Health Impact Fund: globalhealthimpactfund.com/; Peregrine Ventures: www.peregrinevc.com/; Paliwoda Group: www.paliwoda.com.    

 

---

For more episodes from Investor Connect, please visit the site at: http://investorconnect.org  

Check out our other podcasts here: https://investorconnect.org/ 
For Investors check out: https://tencapital.group/investor-landing/ 
For Startups check out: https://tencapital.group/company-landing/ 
For eGuides check out: https:/_/tencapital.group/education/ 
For upcoming Events, check out https://tencapital.group/events/  

For Feedback please contact info@tencapital.group   

Please follow, share, and leave a review.

Music courtesy of Bensound.

Copyright (c) 2024, Hall Martin and investorconnect.org. All rights reserved.

Disclaimer:
Hall T Martin is the director of Investor Connect, which is a 501(c)(3) nonprofit dedicated to the education of investors for early-stage funding. All opinions expressed by Hall and podcast guests are solely their own opinions and do not reflect the opinion of Investor Connect. This podcast is for informational purposes only and should not be relied upon for the basis of investment decisions.